SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-23-128721
Filing Date
2023-12-22
Accepted
2023-12-22 14:15:13
Documents
2
Period of Report
2023-12-13

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2333164-13_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2333164-13_3seq1.xml 3 1622
2 EXHIBIT 24 tm2333164d13_ex24.htm EX-24 16064
  Complete submission text file 0001104659-23-128721.txt   19385
Mailing Address 1900 MARKET STREET SUITE 200 PHILADELPHIA PA 19103
Business Address 1900 MARKET STREET SUITE 200 PHILADELPHIA PA 19103 6177728515
abrdn Life Sciences Investors (Issuer) CIK: 0000884121 (see all company filings)

IRS No.: 043147016 | State of Incorp.: PA | Fiscal Year End: 0930
SIC: 0000

Mailing Address C/O ABERDEEN ASSET MANAGEMENT INC. 1735 MARKET STREET, 32ND FLOOR PHILADELPHIA PA 19103
Business Address
Duitz Joshua (Reporting) CIK: 0001565384 (see all company filings)

Type: 3 | Act: 34 | File No.: 811-06565 | Film No.: 231509206